Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Grace Julia Okoroji"'
Autor:
Amin M. Alousi, Carlos Bueso-Ramos, Zaher Chakhachiro, Stefan O. Ciurea, U. Popat, P. Anderlini, Issa F. Khouri, Richard E. Champlin, M. Körbling, Oran Betul, Grace Julia Okoroji, Barry I. Samuels, L. Jeffrey Medeiros, Rima M. Saliba
Publikováno v:
Cancer. 119:3318-3325
BACKGROUND In the current study, the authors report the results of 39 patients with mantle cell lymphoma (MCL) who were treated with chemotherapy and high-dose rituximab-containing autologous stem cell transplantation (ASCT) during their first diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ff1b076536028baa90aa1bf3309d4fa
https://doi.org/10.1002/cncr.28219
https://doi.org/10.1002/cncr.28219
Autor:
Roy B. Jones, Rima M. Saliba, Anas Younes, Martin Korbling, Luis Fayad, Barbara Pro, Issa F. Khouri, Michele L. Donato, Paolo Anderlini, Marcos de Lima, Daniel R. Couriel, Grace Julia Okoroji, Sandra Acholonu, Peter McLaughlin, Elizabeth J. Shpall, John T. Manning, Richard E. Champlin, Farzaneh Maadani, Segio Giralt, Chitra Hosing
Publikováno v:
Journal of Clinical Oncology. 23:2240-2247
Purpose We investigated the efficacy and safety of administering high-dose rituximab (HD-R) in combination with high-dose carmustine, cytarabine, etoposide, and melphalan chemotherapy and autologous stem-cell transplantation (SCT) in patients with re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c65cd2177d79f2796d0d4d691cebac
https://doi.org/10.1200/jco.2005.08.012
https://doi.org/10.1200/jco.2005.08.012
Autor:
Rima M. Saliba, Sandra Acholonu, Uday R. Popat, Naoto T. Ueno, Paolo Anderlini, Roy B. Jones, Richard E. Champlin, Muzaffar H. Qazilbash, Marcos de Lima, Sergio Giralt, Grace Julia Okoroji, Yago Nieto, Chitra Hosing, Borje S. Andersson, Celina Ledesma
Publikováno v:
Leukemia & Lymphoma. 53:1239-1241
Progressive disease remains the main cause of treatment failure following allogeneic stem cell transplantation (allo-SCT) for Hodgkin lymphoma (HL), and the role of donor leukocyte infusions (DLIs) in the management of disease recurrence is still bei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2855a8f20c1428b5740e2509aa48a0d
https://doi.org/10.3109/10428194.2011.644547
https://doi.org/10.3109/10428194.2011.644547
Autor:
Zaher I, Chakhachiro, Rima M, Saliba, Grace-Julia, Okoroji, Martin, Korbling, Amin M, Alousi, Oran, Betul, Paolo, Anderlini, Stefan O, Ciurea, Uday, Popat, Richard, Champlin, Barry I, Samuels, L Jeffrey, Medeiros, Carlos, Bueso-Ramos, Issa F, Khouri
Publikováno v:
Cancer. 119(18)
In the current study, the authors report the results of 39 patients with mantle cell lymphoma (MCL) who were treated with chemotherapy and high-dose rituximab-containing autologous stem cell transplantation (ASCT) during their first disease remission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da4236c1329bea109526f84acf2b0dae
https://pubmed.ncbi.nlm.nih.gov/23775587
https://pubmed.ncbi.nlm.nih.gov/23775587
Autor:
Gabriela Rondon, Richard E. Champlin, Grace-Julia Okoroji, Daniel R. Couriel, Asif Rashid, Rima M. Saliba, Amin M. Alousi, Sergio Giralt
Publikováno v:
Bone marrow transplantation. 47(1)
One challenge in designing clinical trials for treatment of acute GVHD (aGVHD) is the lack of an established standardized end point to measure the success of therapies. To facilitate assessment of end points in clinical trials for treatment of aGVHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d162c56cf3f0041fbcea1c3c2d5c20f
https://pubmed.ncbi.nlm.nih.gov/21383686
https://pubmed.ncbi.nlm.nih.gov/21383686
Autor:
Elizabeth J. Shpall, Muzaffar H. Qazilbash, Laura L. Worth, Uday R. Popat, Roland Bassett, Richard E. Champlin, Paolo Anderlini, Sergio Giralt, Grace Julia Okoroji, Sandra Acholonu
Publikováno v:
Leukemialymphoma. 52(1)
Twenty severe aplastic anemia (SAA) patients underwent allogeneic stem cell transplantation (allo-SCT) with fludarabine (FLU), cyclophosphamide and antithymocyte globulin from a matched related (n=7, age ≥ 40) or unrelated donor (n=13, any age). Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f737e0d386b57d63b0ec730bdc0c6a
https://pubmed.ncbi.nlm.nih.gov/20939697
https://pubmed.ncbi.nlm.nih.gov/20939697
Autor:
Muzaffar H. Qazilbash, Partow Kebriaei, Rima M. Saliba, Issa F. Khouri, Richard E. Champlin, Uday R. Popat, Amin M. Alousi, Chitra Hosing, Paolo Anderlini, Barry I. Samuels, Marcos de Lima, Sergio Giralt, Grace Julia Okoroji, Martin Korbling, Homer A. Macapinlac
Publikováno v:
British journal of haematology. 142(5)
Summary Tumor status, as determined by positron emission tomography or gallium scanning (PET/G), may be an important predictor of outcome for patients with diffuse large B-cell lymphoma (DLBCL) undergoing autologous stem cell transplantation (ASCT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d968c0b91139319a7111778acd8b872
https://pubmed.ncbi.nlm.nih.gov/18564354
https://pubmed.ncbi.nlm.nih.gov/18564354
Autor:
Issa F. Khouri, Muzaffar H. Qazilbash, Paolo Anderlini, Sergio Giralt, Amin M. Alousi, Partow Kebriaei, Daniel R. Couriel, Rima M. Saliba, M. de Lima, T. Ali, L. De Padua Silva, Richard E. Champlin, Uday R. Popat, Chitra Hosing, Grace-Julia Okoroji
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 19(6)
Patients and methods: We present a retrospective analysis of 99 consecutive patients with relapsed non-Hodgkin’s lymphomas who were older than 65 years at the time of high-dose chemotherapy and autologous progenitor cell transplantation. Results: M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2325bdb61b75be0e0c73fe88144fe03f
https://pubmed.ncbi.nlm.nih.gov/18272911
https://pubmed.ncbi.nlm.nih.gov/18272911
Autor:
Martin Korbling, Marcos de Lima, Sergio Giralt, Grace Julia Okoroji, Daniel R. Couriel, Michele L. Donato, Rima M. Saliba, Sandra Acholonu, Richard E. Champlin, Issa F. Khouri, John McMannis, Paolo Anderlini, Chitra Hosing
Publikováno v:
Leukemialymphoma. 47(7)
Rituximab, an anti-CD20 human-mouse chimeric monoclonal antibody has been shown to improve response rates when it is combined with standard salvage chemotherapy in patients with relapsed or refractory intermediate-grade B-cell non-Hodgkin's lymphoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33de6561c4287309e3906410a3bf9ef4
https://pubmed.ncbi.nlm.nih.gov/16923559
https://pubmed.ncbi.nlm.nih.gov/16923559
Autor:
Andre Goy, M. Donato, Grace-Julia Okoroji, Luis Fayad, Borje S. Andersson, M. de Lima, Richard E. Champlin, Jorge E. Romaguera, Issa F. Khouri, Chitra Hosing, Sandra Acholonu, Panderli Anderlini, Maria A Rodriguez, Barbara Pro, Cindy Ippoliti, Naoto T. Ueno, Sergio Giralt, Rima M. Saliba, Anas Younes, A. Cohen
Publikováno v:
Bone marrow transplantation. 35(10)
A total of 40 patients with relapsed/refractory Hodgkin's disease (HD) underwent reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) from an HLA-identical sibling (n=20) or a matched unrelated donor (n=20). The median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c14e03bc16d850f27c7316c2af3e67e
https://pubmed.ncbi.nlm.nih.gov/15806128
https://pubmed.ncbi.nlm.nih.gov/15806128